NRGN and Alzheimer disease: When applying this cutoff on the CTRL group, the AD biomarker-positive CTRL subjects (n = 9) had significantly higher CSF Ng concentrations than the AD biomarker-negative CTRL group subjects (n = 64, p = 0.03) (Fig. 1b).